Table 1.
Characteristics of patients with Parkinson's disease.
Figure 1.
Quality of life, costs of medication, cost components in the Hoehn&Yahr categories.
A: EQ-5D and VAS scores B: PDQ-39 index scores C: Costs of medication therapy related to Parkinson's disease D: Distribution of cost components. Vertical lines indicate standard deviations.
Figure 2.
EQ-5D results in Parkinson's disease and the general population in Hungary.
Rate of PD patients reporting different levels of problem in the EQ-5D scale, in comparison with the general population in Hungary [11]. PD: Patients with PD, age mean 63.3 (SD: 11.3) years, N = 110; C: control, general population, age-group 60–69 yrs, N = 721.
Table 2.
Resource utilization and costs of patients with Parkinson's disease in Hungary.
Table 3.
Results of the regression analysis models built for the EQ-5D, EQ VAS and PDQ-39 separately.